JP Morgan Upgrades Aetna to "Overweight" (AET)

JP Morgan Upgrades Aetna to “Overweight” (AET)


On Friday analysts at JP Morgan upgraded healthcare insurer Aetna Inc. (AET) to “Overweight” as they expect a positive revision of earnings estimates following the closing of the purchase of Coventry Health.

The analysts upgraded AET from “Neutral” to “Overweight” with a price target of $52. The target is a +19.7% upside from Thursday’s closing price of $43.43.

Aetna shares were flat in premarket trading on Friday. The stock is up +3.4% year-to-date.

The Bottom Line
Shares of Aetna (AET) have a 1.84% dividend yield, based on last night’s closing stock price of $43.43. The stock has technical support in the $39-$40 price area. If the shares can firm up, we see overhead resistance around the $46-$47 price levels.

Aetna Inc. (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today